The Pediatric Praziquantel Consortium is an international public-private partnership that aims to reduce the global disease burden of schistosomiasis by addressing the medical needs of infected preschool-aged children. The neglected tropical disease affects an estimated 250 million people worldwide, including at least 50 million preschool-aged children who are currently lacking adequate treatment. The Consortium operates on a not-for-profit basis.
Company Details
- Founded
- -
- Address
- Jaarbeursplein, 6,netherlands
- Industry
- Non-Profit Organization Management
- Keywords
- H3D Foundation.
- HQ
- Utrecht, Utrecht
Pediatric Praziquantel Consortium Questions
Pediatric Praziquantel Consortium's website is https://www.pediatricpraziquantelconsortium.org/
Pediatric Praziquantel Consortium's LinkedIn profile is https://nl.linkedin.com/company/pediatric-praziquantel-consortium
Pediatric Praziquantel Consortium's industry is
Non-profit Organization Management
Pediatric Praziquantel Consortium's top competitors are
Farmanguinhos / Fiocruz,
Merck Group,
Lygature,
Drugs For Neglected Diseases Initiative (Dndi),
Global Health Innovative Technology (Ghit) Fund,
Unlimit Health,
Wellcome Trust,
H3d Foundation,
Global Health Edctp3,
Jutta Reinhard-Rupp.
Pediatric Praziquantel Consortium's categories are Non-profit Organization Management
Pediatric Praziquantel Consortium's founding year is 2012
